Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02500017 · ClinicalTrials.gov registry record · NA
Melatonin Treatment for Night-Eating Syndrome
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02500017 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 2 participants.
The verdict
NCT02500017, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is an 8-week randomized, double-blind, placebo-controlled, parallel, fixed-dose pilot clinical trial to test the effectiveness of melatonin treatment versus placebo on symptoms of Night Eating Syndrome (NES). The investigators will also look at the effect of melatonin treatment on weight, metabolic parameters and sleep parameters in individuals with NES.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-09-24 |
| Est. Completion | 2017-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02500017
The ClinicalTrials.gov registry entry for NCT02500017 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02500017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02500017 about?
NCT02500017 is a clinical study titled "Melatonin Treatment for Night-Eating Syndrome". This is an 8-week randomized, double-blind, placebo-controlled, parallel, fixed-dose pilot clinical trial to test the effectiveness of melatonin treatment versus placebo on symptoms of Night Eating Syndrome (NES). The investigators will also look at the effect of melatonin treatment on weight, metab...
What is the current status of trial NCT02500017?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2015-09-24. Estimated completion is 2017-04-25.
What interventions are being tested in trial NCT02500017?
The interventions under investigation include: Placebo (OTHER), Melatonin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02500017?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.